PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties.

The in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties of PLGA-mPEG nanoparticles of cisplatin were investigated. The nanoparticles were prepared by a double emulsion method and characterized with regard to their morphology, size, zeta potential and drug loading. The rate of in vitro degradation of the PLGA-mPEG nanoparticles in PBS (pH 7.4) depended on their composition, increasing when the mPEG content (mPEG:PLGA ratio) of the nanoparticles increased. Sustained cisplatin release over several hours from the PLGA-mPEG nanoparticles in vitro (PBS) was observed. The composition of the nanoparticles affected drug release: the rate of release increased when the mPEG content of the nanoparticles increased. Within the range of drug loadings investigated, the drug loading of the nanoparticles did not have any significant effect on drug release. The loading efficiency was low and needs improvement in order to obtain PLGA-mPEG nanoparticles with a satisfactory cisplatin content for therapeutic application. The i.v. administration of PLGA-mPEG nanoparticles of cisplatin in BALB/c mice resulted in prolonged cisplatin residence in systemic blood circulation. The results appear to justify further investigation of the suitability of the PLGA-mPEG nanoparticles for the controlled i.v. delivery and/or targeting of cisplatin.

[1]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[2]  K. Ushijima,et al.  Improvement of Intraperitoneal Chemotherapy for Rat Ovarian Cancer Using Cisplatin‐containing Microspheres , 1996, Japanese journal of cancer research : Gann.

[3]  Y. Ogawa,et al.  Increased tumor cisplatin levels in heated tumors in mice after administration of thermosensitive, large unilamellar vesicles encapsulating cisplatin. , 1991, Journal of pharmaceutical sciences.

[4]  M A Egea,et al.  Entrapment of cisplatin into biodegradable polyalkylcyanoacrylate nanoparticles. , 1994, Farmaco.

[5]  M. Newman,et al.  Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice , 1999, Cancer Chemotherapy and Pharmacology.

[6]  M. Wilchek,et al.  Soluble polymers as carriers of cis-platinum , 1989 .

[7]  Robert J. Levy,et al.  Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery , 1997 .

[8]  Y. Sugiyama,et al.  Cisplatin-Loaded Polymer-Metal Complex Micelle with Time-Modulated Decaying Property as a Novel Drug Delivery System , 2001, Pharmaceutical Research.

[9]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[10]  R. Duncan,et al.  Synthesis, characterisation and antitumour activity of platinum(II) complexes of novel functionalised poly(amido amine)s , 1999 .

[11]  Allan G. A. Coombes,et al.  Surface Modification of Poly(lactide-co-glycolide) Nanospheres by Biodegradable Poly(lactide)-Poly(ethylene glycol) Copolymers , 1994, Pharmaceutical Research.

[12]  J. Feijen,et al.  Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake , 1999, Pharmaceutical Research.

[13]  R. Duncan,et al.  HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo. , 1999, European journal of cancer.

[14]  T. Kissel,et al.  Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(l-lactic acid) or poly (l-lactic-co-glycolic acid) A-blocks attached to central poly ( oxyethylene ) B-blocks , 1993 .

[15]  D. Bazile,et al.  Degradation of poly(D,L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII). , 1996, Biomaterials.

[16]  G. Kwon,et al.  Diblock copolymer nanoparticles for drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.

[17]  R. Gref,et al.  MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties. , 1999, Journal of biomedical materials research.

[18]  A. Göpferich,et al.  Erosion of biodegradable block copolymers made of poly(D,L-lactic acid) and poly(ethylene glycol). , 1997, Biomaterials.

[19]  F. Martin,et al.  Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. , 1992, Cancer research.

[20]  T. Tani,et al.  Antitumor effect of cisplatin incorporated into polylactic acid microcapsules. , 1999, Artificial organs.

[21]  Y Li,et al.  PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Barnett Rosenberg,et al.  Charles F. Kettring prize. Fundamental studies with cisplatin , 1985 .

[23]  E. Chiotellis.  Preparation of Tc-99m labeled pyridoxal-amino acid complexes and their evaluation. , 1977, International journal of nuclear medicine and biology.

[24]  G. Sims,et al.  A method for the estimation of polyethylene glycol in plasma protein fractions. , 1980, Analytical biochemistry.

[25]  Robert Langer,et al.  PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1 , 1997 .

[26]  P. Ferruti,et al.  Degradation behaviour of block copolymers containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments. , 1996, Biomaterials.

[27]  K. Avgoustakis,et al.  Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery. , 1999, International journal of pharmaceutics.

[28]  R. Duncan,et al.  Dendrimer-platinate: a novel approach to cancer chemotherapy. , 1999, Anti-cancer drugs.